| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 893 |
| 1 | INFLIXIMAB | 893 |
| 2 | VEDOLIZUMAB | 606 |
| 3 | PREDNISONE | 536 |
| 4 | METHOTREXATE SODIUM | 493 |
| 5 | METHOTREXATE | 427 |
| 6 | AZATHIOPRINE | 413 |
| 7 | USTEKINUMAB | 392 |
| 8 | INFLIXIMAB-DYYB | 302 |
| 9 | METRONIDAZOLE | 264 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 302 | 0.0876 |
| 1 | DIBUCAINE 1% | 2 | 0.0174 |
| 2 | ADALIMUMAB-AFZB | 42 | 0.0157 |
| 3 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 3 | 0.0121 |
| 4 | SODIUM HYPOCHLORITE | 3 | 0.0115 |
| 5 | BENZOCAINE AND MENTHOL | 3 | 0.0113 |
| 6 | GOLIMUMAB | 121 | 0.0096 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 40 | 0.0088 |
| 8 | MESALAMINE | 240 | 0.0085 |
| 9 | CLINDAMYCIN PHOSPHATE | 46 | 0.0083 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1539 |
| 1 | Corticosteroid [EPC] | 1012 |
| 2 | Integrin Receptor Antagonist [EPC] | 626 |
| 3 | Interleukin-23 Antagonist [EPC] | 489 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 441 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 428 |
| 6 | Purine Antimetabolite [EPC] | 427 |
| 7 | Interleukin-12 Antagonist [EPC] | 395 |
| 8 | Proton Pump Inhibitor [EPC] | 311 |
| 9 | Aminosalicylate [EPC] | 290 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 626 | 0.0072 |
| 1 | Provitamin D2 Compound [EPC] | 171 | 0.0057 |
| 2 | Interleukin-23 Antagonist [EPC] | 489 | 0.0047 |
| 3 | Purine Antimetabolite [EPC] | 427 | 0.0043 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 265 | 0.0040 |
| 5 | Interleukin-12 Antagonist [EPC] | 395 | 0.0038 |
| 6 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 7 | Leptin Analog [EPC] | 4 | 0.0032 |
| 8 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 9 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |